As our aim was to select an antibody capable of neutralizing human pathological tau, we used a standard sarkosyl extraction method to enrich fibrillar Tau from pools of > 20 AD brains for use as seeding material in subsequent experiments. This evidence concerns the gene MAPT and Alzheimer disease.